Literature DB >> 22109873

Tay-Sachs disease preconception screening in Australia: self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421 + 1G > C mutation in individuals with South African heritage.

Raelia Lew1, Leslie Burnett, Anné Proos.   

Abstract

The Australasian Community Genetics Program provided a preconception screening for Tay-Sachs disease (TSD) to 4,105 Jewish high school students in Sydney and Melbourne over the 12-year period 1995-2007. By correlating the frequencies of mutant HEXA, MIM *606869 (gene map locus 15q23-q24) alleles with subjects' nominated ethnicity (Ashkenazi/Sephardi/Mixed) and grandparental birthplaces, we established that Ashkenazi ethnicity is a better predictor of TSD carrier status than grandparental ancestral origins. Screening self-identified Ashkenazi subjects detected 95% of TSD carriers (carrier frequency 1:25). Having mixed Ashkenazi and non-Ashkenazi heritage reduced the carrier frequency (1:97). South African heritage conveyed a fourfold risk of c.1421 + 1G > C mutation compared with other AJ subjects (odds ratio (OR), 4.19; 95% confidence interval (CI), 1.83-9.62, p = 0.001), but this was the only specific case of ancestral origin improving diagnostic sensitivity over that based on determining Ashkenazi ethnicity. Carriers of c.1278insTATC mutations were more likely to have heritage from Western Europe (OR, 1.65 (95% CI, 1.04-2.60), p = 0.032) and South Eastern Europe (OR, 1.77 (95% CI, 1.14-2.73), p = 0.010). However, heritage from specific European countries investigated did not significantly alter the overall odds of TSD carrier status.

Entities:  

Year:  2011        PMID: 22109873      PMCID: PMC3215783          DOI: 10.1007/s12687-011-0057-x

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  32 in total

1.  Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.

Authors:  D B Goldstein; D E Reich; N Bradman; S Usher; U Seligsohn; H Peretz
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease.

Authors:  J Ekstein; H Katzenstein
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

3.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

Review 4.  Prevention of lysosomal storage disorders in Israel.

Authors:  Gideon Bach; Marsha Zeigler; Joel Zlotogora
Journal:  Mol Genet Metab       Date:  2006-12-18       Impact factor: 4.797

5.  Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.

Authors:  B L Triggs-Raine; A S Feigenbaum; M Natowicz; M A Skomorowski; S M Schuster; J T Clarke; D J Mahuran; E H Kolodny; R A Gravel
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

6.  Tay-Sachs screening and prevention: the Canadian experience.

Authors:  J A Lowden; J Davidson
Journal:  Prog Clin Biol Res       Date:  1977

7.  Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.

Authors:  B H Paw; S M Moskowitz; N Uhrhammer; N Wright; M M Kaback; E F Neufeld
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

8.  Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.

Authors:  E H Mules; S Hayflick; C S Miller; L W Reynolds; G H Thomas
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

9.  A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.

Authors:  V Meiner; D Landsberger; N Berkman; A Reshef; P Segal; H C Seftel; D R van der Westhuyzen; M S Jeenah; G A Coetzee; E Leitersdorf
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

10.  Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling.

Authors:  Alexandra A Gason; Sylvia A Metcalfe; Martin B Delatycki; Vicki Petrou; Edith Sheffield; Agnes Bankier; Maryanne Aitken
Journal:  Genet Med       Date:  2005 Nov-Dec       Impact factor: 8.822

View more
  1 in total

Review 1.  Tay-Sachs disease: current perspectives from Australia.

Authors:  Raelia M Lew; Leslie Burnett; Anné L Proos; Martin B Delatycki
Journal:  Appl Clin Genet       Date:  2015-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.